These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9289430)

  • 1. [GnRH analogs for treatment of ovarian cancer].
    Kośmider M
    Ginekol Pol; 1996 Oct; 67(10):499-503. PubMed ID: 9289430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GnRH analogues as an adjuvant therapy for ovarian cancer patients.
    Rzepka-Górska I; Chudecka-Glaz A; Kosmider M; Malecha J
    Int J Gynaecol Obstet; 2003 May; 81(2):199-205. PubMed ID: 12706278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Goserelin reduces chemotherapy-associated ovarian failure.
    Mayor S
    Lancet Oncol; 2015 Apr; 16(4):e160. PubMed ID: 25754677
    [No Abstract]   [Full Text] [Related]  

  • 4. Treating relapsed epithelial ovarian cancer with luteinizing hormone-releasing agonist (goserelin) after failure of chemotherapy.
    Zidan J; Zohar S; Mijiritzky I; Kral S; Bilenca B
    Isr Med Assoc J; 2002 Aug; 4(8):597-9. PubMed ID: 12183859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of ovarian ablation with goserelin in a pre-menopausal breast cancer patient resulting in pregnancy: a case report and review of the literature.
    Hill N; Madarnas Y
    Breast Cancer Res Treat; 2011 Aug; 129(1):265-8. PubMed ID: 21541703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of prostate cancer with goserelin and radiotherapy.
    Schoen SS
    N Engl J Med; 1997 Dec; 337(23):1693; author reply 1694. PubMed ID: 9411235
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of premenopausal women with early-stage breast cancer: is there a role for ovarian suppression?
    Baum M; O'Shaughnessy JA
    Clin Breast Cancer; 2002 Oct; 3(4):260-7. PubMed ID: 12425754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing a patient with presumed testosterone-secreting ovarian tumor.
    Lee WL; Wang PH; Tseng HS; Lin HD; Yuan CC; Chao HT
    Gynecol Oncol; 1999 Oct; 75(1):175-7. PubMed ID: 10502449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Goserelin can inhibit ovarian cancer proliferation and simultaneously protect ovarian function from cisplatin: an in vitro and in vivo study.
    Zhang Y; Ding JX; Tao X; Lu ZY; Wang JJ; Feng WW; Hua KQ
    J Chemother; 2013 Apr; 25(2):96-103. PubMed ID: 23684357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drawbacks of ovarian ablation with goserelin in women with breast cancer].
    Franco S; Lupa P; Guerra C; Pereira L; Oliveira CF
    Acta Med Port; 2005; 18(2):123-7. PubMed ID: 16202345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin.
    Bolla M; Gonzalez D; Warde P; Dubois JB; Mirimanoff RO; Storme G; Bernier J; Kuten A; Sternberg C; Gil T; Collette L; Pierart M
    N Engl J Med; 1997 Jul; 337(5):295-300. PubMed ID: 9233866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of goserelin ovarian ablation in premenopausal women with breast cancer: two case reports.
    Jiménez-Gordo AM; de las Heras B; Zamora P; Espinosa E; González-Barón M
    Gynecol Oncol; 2000 Jan; 76(1):126-7. PubMed ID: 10620455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Update of the study on survival with early hormonal therapy associated with radiotherapy (EORTC 22863 Study) in patients with advanced prostatic cancer. Interview with Michel Bolla].
    Bolla M
    Recenti Prog Med; 2001 Feb; 92(2):128-9. PubMed ID: 11294104
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of goserelin in the treatment of breast cancer.
    Rody A; Loibl S; von Minckwitz G; Kaufmann M
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):591-604. PubMed ID: 16111461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Goserelin and locally advanced prostate cancer: new indication. Pros and cons.
    Prescrire Int; 2000 Jun; 9(47):75-6. PubMed ID: 11010743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
    Paterson WF; McNeill E; Young D; Donaldson MD
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pregnancy in nullipara after conservative excision of uterine cellular leiomyoma and supplementary GnRH analog therapy].
    Cyrkowicz A; Fiala J; Wilkoszewski R
    Ginekol Pol; 1998 Feb; 69(2):91-3. PubMed ID: 9591388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating prostate cancer: another step forward.
    Harv Mens Health Watch; 1998 May; 2(10):7. PubMed ID: 9577263
    [No Abstract]   [Full Text] [Related]  

  • 19. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.
    Messing EM; Manola J; Sarosdy M; Wilding G; Crawford ED; Trump D
    N Engl J Med; 1999 Dec; 341(24):1781-8. PubMed ID: 10588962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular leiomyoma mimicking endometrial stromal neoplasm in association with GnRH agonist goserelin.
    McCluggage WG; Bharucha H
    Histopathology; 1999 Feb; 34(2):184-6. PubMed ID: 10064405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.